Money Concepts Capital Corp Sells 197 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Money Concepts Capital Corp trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,033 shares of the medical equipment provider’s stock after selling 197 shares during the quarter. Money Concepts Capital Corp’s holdings in Intuitive Surgical were worth $1,583,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Intuitive Surgical by 9.8% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 202,275 shares of the medical equipment provider’s stock worth $107,371,000 after purchasing an additional 18,052 shares during the period. Lockheed Martin Investment Management Co. raised its position in Intuitive Surgical by 18.9% during the 4th quarter. Lockheed Martin Investment Management Co. now owns 10,070 shares of the medical equipment provider’s stock worth $5,256,000 after purchasing an additional 1,600 shares during the last quarter. Jackson Wealth Management LLC raised its position in Intuitive Surgical by 46.3% during the 4th quarter. Jackson Wealth Management LLC now owns 1,027 shares of the medical equipment provider’s stock worth $536,000 after purchasing an additional 325 shares during the last quarter. Weaver Capital Management LLC increased its stake in shares of Intuitive Surgical by 10.7% in the fourth quarter. Weaver Capital Management LLC now owns 2,578 shares of the medical equipment provider’s stock valued at $1,346,000 after buying an additional 249 shares during the period. Finally, Stratos Investment Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $215,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 28,843 shares of company stock worth $15,357,560 in the last quarter. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Up 1.9 %

ISRG opened at $590.90 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market cap of $210.47 billion, a price-to-earnings ratio of 92.18, a PEG ratio of 5.51 and a beta of 1.39. The company’s fifty day moving average price is $551.99 and its two-hundred day moving average price is $512.04.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. CICC Research assumed coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective on the stock. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, Raymond James increased their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.